Involving patients and the public in research.

Nurse Res

Scottish Dementia Clinical Research Network, Royal Cornhill Hospital, Aberdeen, UK.

Published: July 2013

Aim: To present the actions taken by the Scottish Dementia Clinical Research Network (SDCRN) to comply with Scotland's National Dementia Strategy (SNDS) on patient and public involvement (PPI).

Background: Tackling priorities in dementia research is paramount to success in planning and delivering effective health services. Identifying such priorities is a task that should involve patients with dementia and their carers. Aware of the potential importance that the public has in shaping the future of dementia research, the Scottish Government has launched an initiative that places PPI at its core. The SDCRN, funded by the Chief Scientist Office, has responded to this initiative and has developed a strategic PPI agenda.

Data Sources: Experience of developing and implementing an extensive range of PPI activities with patients with dementia and their carers in Scotland.

Review Methods: This is an informative paper.

Discussion: The paper discusses the strategy that the SDCRN has adopted to comply with government PPI priorities, thus supporting the strategic agenda for Scottish topic-specific research networks.

Conclusion: The challenges that researchers face when engaging with patients with dementia and their carers can be overcome by promoting a culture that supports dementia research. Through the development of the PPI strategy, the SDCRN has encouraged and enabled the public to become active partners in research.

Implications For Practice/research: Involving the public in dementia research is a priority. This paper highlights how this can be achieved through extensive partnership working, collaboration and the implementation of various PPI activities to allow the public to play a major influential role in the development of future dementia services.

Download full-text PDF

Source
http://dx.doi.org/10.7748/nr2013.07.20.6.21.e341DOI Listing

Publication Analysis

Top Keywords

patients dementia
12
dementia carers
12
dementia
10
future dementia
8
ppi activities
8
strategy sdcrn
8
public
6
ppi
6
involving patients
4
patients public
4

Similar Publications

Changes in cerebrovascular reactivity as a marker of cognitive impairment risk: a transcranial Doppler study.

J Ultrasound

January 2025

Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste, ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.

Introduction: Post-stroke cognitive impairment (PSCI) and dementia affect short- and long-term outcome after stroke and can persist even after recover from a physical handicap. The process underlying PSCI is not yet fully understood. Transcranial Doppler ultrasound (TCD) is a feasible method to investigate cerebrovascular aging or dementia, through the pulsatility index (PI), the cerebrovascular reactivity (e.

View Article and Find Full Text PDF

Aims: To study differences in cardiovascular prevention and hypertension management in primary care in men and women, with comparisons between public and privately operated primary health care (PHC).

Methods: We used register data from Region Stockholm on collected prescribed medication and registered diagnoses, to identify patients aged 30 years and above with hypertension. Age-adjusted logistic regression was used to calculate odds ratios (ORs) with 99% confidence intervals (99% CIs) using public PHC centers as referents.

View Article and Find Full Text PDF

Cerebral perfusion correlates with amyloid deposition in patients with mild cognitive impairment due to Alzheimer's disease.

J Prev Alzheimers Dis

February 2025

Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, 154 Anshan Road Tianjin 300052, PR China; Department of Neurology, Tianjin Medical University General Hospital Airport Site, Tianjin 300052, PR China. Electronic address:

Background: Changes in cerebral blood flow (CBF) may contribute to the initial stages of the pathophysiological process in patients with Alzheimer's disease (AD). Hypoperfusion has been observed in several brain regions in patients with mild cognitive impairment (MCI). However, the clinical significance of CBF changes in the early stages of AD is currently unclear.

View Article and Find Full Text PDF

Background: α-Synuclein (α-Syn) pathology is present in 30-50 % of Alzheimer's disease (AD) patients, and its interactions with tau proteins may further exacerbate pathological changes in AD. However, the specific role of different aggregation forms of α-Syn in the progression of AD remains unclear.

Objectives: To explore the relationship between various aggregation types of CSF α-Syn and Alzheimer's disease progression.

View Article and Find Full Text PDF

Determinants of dementia diagnosis in U.S. primary care in the past decade: A scoping review.

J Prev Alzheimers Dis

February 2025

Department of Health Behavior and Health Equity, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109-2029, United States.

Background: Alzheimer's disease and related dementias (ADRD) are chronically underdiagnosed in the U.S., particularly among minoritized racial and ethnic groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!